Diffusion tensor imaging, an MRI technique, showed that significant differences in the brains of high-risk children who go on to develop autism can be seen before symptoms appear.
Diffusion tensor imaging (DTI), a magnetic resonance imaging technique, showed that significant differences in the brains of high-risk children who go on to develop autism can be seen before symptoms appear.
This is according to a study from the Center of Autism Research at the Children’s Hospital of Philadelphia (CHOP).
“[The] findings, while requiring replication, are a very important first step towards identifying a biomarker for autism risk,” said Sara Paterson, PhD, director of the Infant Neuroimaging Lab at the Center, and a co-author of the study.
Ninety-two high-risk infants (siblings of children with autism) underwent DTI at 6 months and behavioral assessments at 24 months. Most also received other imaging exams at 12 months and/or 24 months. The researchers found that the factional anisotropy (FA) trajectories for 12 of 15 fiber tracts were significantly different between 28 infants at 6 months who at 24 months met the criteria for autism spectrum disorders (ASD) and the 64 who did not.
The infants diagnosed with an ASD had elevated FA at age 6 months, but slower development over time, which resulted in lower FA values at 24 months than had the other infants. The study was published in the American Journal of Psychiatry.
More studies are needed to confirm these findings but this discovery would allow for early intervention, which has been shown to improve outcomes among children with an ASD.
“This would enable specialists to diagnose autism much earlier than is currently possible through behavioral observations,” said Patterson.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.